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Diffuse fi bromuscular dysplasia successfully treated with scoring balloon 
angioplasty in a 3-year-old boy
Abstract In children, up to 10% of the cases of arterial 
hypertension may be caused by a renovascular disease. The 
etiology of this renovascular disease is most of the time due 
to a fi bromuscular dysplasia (FMD), which causes a nonin-
fl ammatory intimal–medial fi broplasia leading to luminal 
compromise. Percutaneous transluminal angioplasty of 
FMD is a worldwide-accepted treatment modality for this 
serious arterial disease with, so far, good safety and long-
term effi cacy data. Once FMD involves several arterial 
compartments leading to symptoms the outcomes are poor. 
Herein we report the case of a 3½-year-old boy with severe 
arterial hypertension and abdominal angina due to a diffuse 
multivisceral FMD involvement, successfully managed by a 
percutaneous angioplasty approach using a new balloon 
catheter for plaque modulation.
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Introduction
In children, arterial hypertension may be caused, in up to 
10% of the cases, by renovascular diseases.1 Most children 
presenting with renovascular hypertension have few if any 
symptoms, but if untreated, devastating complications (e.g., 
neurologic injury and congestive heart failure) may occur. 
The etiology of this juvenile renovascular disease is most of 
the time due to a fi bromuscular dysplasia (FMD), followed 
by Takayasu arteritis, neurofi bromatosis, and other rare 
syndromes.1
Fibromuscular dysplasia is a nonatherosclerotic, nonin-
fl ammatory arteriopathy characterized by intimal, medial, 
and/or adventitial fi broplasias leading to luminal compro-
mise, aneurysm formation, or arterial dissection. The patho-
logical classifi cation of fi bromuscular lesions is based on the 
arterial layer in which the lesion predominates. Medial 
fi broplasia represents the most common dysplastic lesion, 
followed by intimal fi broplasia, which occurs in less than 
10% of cases, and adventitial (periarterial) hyperplasia, 
which is the rarest type.2 The natural history of renal FMD 
includes, in up to 37% of the patients, the progression of 
the angiographic disease (i.e., occurrence of new focal 
lesions, worsening of arterial stenosis), or the enlargement 
of a mural aneurysm.3
Fibromuscular dysplasia mostly affects the renal and the 
carotid arteries but it may involve several other muscular 
arterial compartments, including the celiac and the mesen-
teric arteries and the iliac arteries. The clinical presentation 
may vary from an asymptomatic condition to a multiorganic 
disease that mimics necrotizing vasculitis. This variety of 
symptoms depends on the arterial segment involved, the 
degree of stenosis, and the type of fi bromuscular dysplasia. 
Usually, in the case of multiple symptoms, if FMD is not 
promptly treated the outcomes are poor.4
Because of the absence of specifi c symptoms, the diag-
nosis of FMD may be challenging and most of the time it 
remains speculative. However, the combination of the clini-
cal history and the characteristic angiographic imaging are 
suffi cient to suggest this pathology.
For nearly 30 years, percutaneous transluminal renal 
angioplasty (PTRA) has been used to treat renovascular 
diseases and the fi rst described case of PTRA in a child was 
reported in the early 1980s.5 Renal angioplasty, especially 
in the case of FMD, is nowadays the treatment of choice 
for renovascular hypertension,6 and its effi cacy and safety, 
also in children, has already been suggested in several 
reports.7,8
The percutaneous treatment of FMD is also described in 
all vascular fi elds.9 However, to the best of our knowledge, 
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this minimally invasive approach in more than one arterial 
sector, and especially in a child, has so far never been 
reported.
Here we report the case of a 3½-year-old boy with severe 
arterial hypertension and abdominal angina due to a diffuse 
multivisceral FMD involvement. The boy was successfully 
managed by a percutaneous angioplasty approach using a 
new balloon catheter for plaque modulation, with a 12-
month favorable outcome thus far.
Case report
In December 2006, a 3½-year-old boy was found to have 
arterial hypertension (right arm: 148/52 [84] mmHg, left 
arm: 140/60 [87] mmHg) during a routine examination by 
his pediatric physician. After having excluded other pos-
sible etiologies of the arterial hypertension and following 
the discovery of a high peripheral blood renin level, a reno-
vascular hypertension was suspected and fi nally confi rmed 
by a selective renal and abdominal angiography which 
showed a diffuse multivisceral FMD involving both renal 
arteries, the superior mesenteric artery (SMA), and the 
splenic artery.
Under strict creatinine surveillance (i.e., potential risk 
of decreasing the glomerular fi ltration rate by giving 
angiotensin-converting enzyme inhibitors in case of reno-
vascular hypertension), the pediatric physician initiated a 
regimen of enalapril 2.5 mg b.i.d. and metoprolol 12,5 mg 
b.i.d. With this antihypertensive combination, a few days 
thereafter the boy experienced postprandial abdominal 
pains, which were interpreted as an abdominal angina due 
to the newly developed relative hypotension. Despite having 
suspended the beta-blocker, the abdominal angina persisted 
and the blood pressure rose again (131/83 [99] mmHg). 
Finally the boy was sent to our tertiary center for the per-
cutaneous management of this multivisceral FMD.
Intervention
The intervention was performed under general anesthesia. 
A 5-F Internal Mammary guiding catheter was selectively 
placed in the left renal artery. A 0.014-inch guidewire was 
then easily advanced through the main artery stenosis and 
a 2.0-mm coronary angioplasty balloon was utilized to dilate 
the most relevant stenosis. Due to an important elastic 
recoil at all dilated segments, despite several prolonged 
balloon infl ations and the administration of intra-arterial 
nitroglycerine, we decided to utilize a 2.5-mm Scoring 
Balloon (AngioSculpt, AngioScore, Fremont, CA, USA), 
which with its special laser-cut nitinol spiral scoring ele-
ments could better “break” the membranous septa of the 
FMD stenoses, thus achieving a better fi nal result (Fig. 
1A,B). For the right renal artery and the SMA a Judkins 
Right guiding catheter was adopted and similarly to the left 
kidney, the most severe stenoses were initially treated with 
a 2.5-mm coronary angioplasty balloon. Again, an insuffi -
cient angiographic result was obtained. Thereby, all the 
lesions were additionally dilated with the same 2.5-mm 
Scoring Balloon (Fig. 2) for the renal artery and a 3.0-mm 
one for the SMA. Due to technical diffi culties in catheter-
izing the truncus coeliacus and the already advanced proce-
dural time, the splenic artery stenosis was not treated in this 
session. Femoral access hemostasis was obtained with a D-
Stat Dry hemostatic bandage (Vascular Solutions, Maple 
Grove, MN, USA). After discharge, the boy’s parents were 
instructed to give him Aspirin 50 mg for 4 weeks.
At the 6-month follow-up visit blood pressure was 112/86 
[95] mmHg, despite the fact that the boy did not take any 
antihypertensive medication and at 12 months, according to 
his age/height percentile interpretation, he had a persistent 
but still signifi cantly improved systolic hypertension (121/63 
[82] mmHg). The kidney function did not change signifi -
cantly (pre-interventional: creatinine value: 0.2 mg/dl, at 6 
months: 0.3 mg/dl), and the boy had so far no recurrence of 
abdominal angina.
Discussion
Fibromuscular dysplasia of the renal arteries is usually sus-
pected in young patients presenting with severe or newly 
developed arterial hypertension.1 This case highlights 
how FMD can be a diffuse disease involving more than one 
organ, and how the conservative management of this mul-
tivisceral disease can be diffi cult when multiple symptoms 
are already present.4
Despite the young age of the patient, the vicious circle 
of abdominal angina due to antihypertensive drugs, which 
could not be suspended, mandates the attempt of this off-
Fig. 1A,B. Left renal artery angiography before (A) and after (B) 
the 2.5-mm Scoring Balloon angioplasty (arrows show the dilated 
segments)
Fig. 2. Scoring Balloon with special laser-cut nitinol spiral scoring 
elements wrapping around a conventional nylon angioplasty balloon 
(AngioSculpt, AngioScore, Fremont, CA, USA)
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label percutaneous renal and mesenterial angioplasty. In 
the case of FMD renal lesions, PTRA is the fi rst-line treat-
ment and stenting should be reserved only as bailout 
procedure in case of a suboptimal result after balloon angio-
plasty or renal artery dissection. In our patient insuffi cient 
angiographic results with severe elastic recoil formed the 
rationale to continue the intervention with a lesion modu-
lating catheter device like a Scoring or a Cutting Balloon. 
Due to a better crossing profi le (<2.7 F of the distal shaft) 
compared to standard Cutting Balloons and very small 
balloon diameters (from 2.0 up to 5.0 mm), Scoring Bal-
loons are probably the best alternative after PTRA failure, 
and this especially by treating small FMD renal arteries as 
observed in children.
As recently shown in different trials, a signifi cantly low 
dissection rate compared to standard balloon angioplasty 
(∼13% vs ∼30%), no device slipping for more accurate 
placement, and no “geographic miss,” are other advantages 
of this new Scoring Balloon technology.10,11 These points are 
very important to take into consideration especially in per-
forming percutaneous interventions in children, in whom 
stenting should be avoided because of the theoretical future 
stent-undersizing due to the continuous growth of the vessel 
diameter during childhood. Because FMD is secondary to 
an intimal–medial arterial fi broplasia, angioplasty alone, 
especially if performed with a Scoring or a Cutting Balloon, 
is most of the time suffi cient to break these fi brodysplastic 
membranes, thus assuring a near normal vessel lumen with 
an acceptable long-term patency rate.6,12
Even if children’s FMD treated by PTRA is already 
largely reported,7,8 to the best of our knowledge, this is the 
fi rst described case where a successful angioplasty using a 
plaque modulation technology was performed on a 3½-
year-old boy, in both renal arteries and in the mostly dis-
eased branches of the SMA. Furthermore, the mid-term 
favorable outcome (no recurrence of hypertension or 
abdominal angina) suggests the safety and effi cacy of this 
procedure also in children.10,11
In conclusion, our case confi rms that even in young chil-
dren affected by symptomatic multivisceral FMD, percuta-
neous arterial angioplasty is technically feasible, safe, and 
effi cacious in terms of symptoms regression, thus suggesting 
that angioplasty should be rapidly proposed before the 
affected organs are irreversibly damaged. Furthermore, in 
case of immediate angiographic failure with standard 
balloon angioplasty, Scoring Balloons offer a valid and effi -
cacious solution to better modulate these FMD lesions 
where, especially in children, stent implantations are rela-
tively counter-indicated.
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